Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Hillhouse Capital Leads $230m Series B Preferred Stock Financing In Us Biopharmaceutical Firm Gossamer Bio – China Money Network
Venture Capital

Hillhouse Capital Leads $230m Series B Preferred Stock Financing In Us Biopharmaceutical Firm Gossamer Bio – China Money Network

by chinamoneynetwork.com posted 3weeks ago 179 views
Hillhouse Capital has led a US$230 million series B preferred stock financing in San Diego-based biopharmaceutical firm Gossamer Bio, according to the latter’s announcement. New investors participating in this financing include among others, a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA), Invus, The Baupost Group and Polaris Partners. Gossamer Bio’s existing investors, ARCH Venture Partners and Omega Funds, also meaningfully participated.